Acute Leukemia

March 8, 2009

Developments in the Treatment of Acute Lymphoblastic Leukemia

Charles H. Weaver, MD
March 8, 2009

G-CSF May Improve Cancer-Free Survival in Acute Myeloid Leukemia

Charles H. Weaver, MD
March 8, 2009

Adolescents and Young Adults with AML May Benefit from Pediatric Protocols

Charles H. Weaver, MD
March 8, 2009

Insufficient Chemotherapy Reduces the Chance of Cure in Good Risk AML Patients

Charles H. Weaver, MD
March 8, 2009

Study Suggests Treatment of Acute Myeloid Leukemia May Be Shortened

Charles H. Weaver, MD
March 8, 2009

Children with ALL Treated with Radiation to Brain Suffer Long-Term Side Effects

Charles H. Weaver, MD
March 8, 2009

Prednisone-Resistant ALL Achieves Outcomes with Aggressive BFM Treatment

Charles H. Weaver, MD
March 8, 2009

High Survival Rates Reported for Infants with Acute Leukemia

Charles H. Weaver, MD
March 8, 2009

Substitution of Dexamethasone in ALL Treatment Leads to Fatal Side Effects

Charles H. Weaver, MD
March 8, 2009

Children with Acute Lymphocytic Leukemia and Down Syndrome Benefit from Therapy

Charles H. Weaver, MD
March 8, 2009

Matched Unrelated Donors Prove Effective for Transplantation in ALL

Charles H. Weaver, MD
March 8, 2009

Mercaptopurine Remains Choice of Maintenance Therapy for Pediatric ALL

Charles H. Weaver, MD